References
- 1. Ruxandra Calin, Adriana Hristea, Radu Tanasescu (2012). Central Nervous System Involvement in Lyme Disease - Making the Diagnosis and Choosing the Correct Treatment, Miscellanea on Encephalopathies, Radu Tanasescu (Ed.), ISBN: 978-953-51-0499-5, InTech, DOI: 10.5772/37669.10.5772/37669
- 2. Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol. 2009;30(6):1079-87. doi: 10.3174/ajnr.A1579.10.3174/ajnr.A1579
- 3. Blanc F, Gebly. Neurologic and psychiatric manifestations of Lyme disease. Medecine et Maladies Infectieuses 2007;37(7-8):435-445.10.1016/j.medmal.2006.01.025
- 4. Zhang Y, Lafontant G, Bonner FJ Jr. Lyme neuroborreliosis mimics stroke: a case report. Arch Phys Med Rehabil. 2000;81(4):519-521.10.1053/mr.2000.4431
- 5. Garcia-Monco JC, Benach JI. Lyme neuroborreliosis. Ann Neurol. 1995;37:691-702.10.1002/ana.410370602
- 6. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore). 1979;58(4):281-294.10.1097/00005792-197907000-00001
- 7. Steere AC. Lyme disease. N Engl J Med 2001;345(2):115-125.10.1056/NEJM200107123450207
- 8. Subedi S, Dickeson DJ, Branley JM. First report of Lyme neuroborreliosis in a returned Australian traveller. Med J Aust. 2015;203(1):39-40.10.5694/mja14.01592
- 9. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362(9396):1639-1647.10.1016/S0140-6736(03)14798-8
- 10. Rahn DW, Felz MW. Lyme disease update. Current approach to early, disseminated, and late disease. Postgrad Med. 1998;103(5):51-4,57-9,63-4passim.10.3810/pgm.1998.05.4829590986
- 11. Dessau RB, Espenhain L, Mølbak K, Krause TG, Voldstedlund M. Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012. Euro Surveill. 2015;20(28).pii:21184.10.2807/1560-7917.ES2015.20.28.21184
- 12. Tobias A Rupprecht, Volker Fingerle. Neuroborreliosis: pathogenesis, symptoms, diagnosis and treatment. Future Neurology. 2011;6(2):273-289. DOI: 10.2217/fnl.10.89.10.2217/fnl.10.89
- 13. Jassam YN, Thaler DE. Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA. Oxf Med Case Reports. 2014;2014(9):162-163. doi: 10.1093/omcr/omu061. eCollection 2014.10.1093/omcr/omu061
- 14. Halperin JJ. Nervous system lyme disease: is there a controversy? Semin Neurol. 2011;31(3):317-324. doi: http://dx.doi.org/10.1055/s-0031-1287652.
- 15. Halperin JJ. Chronic Lyme disease: misconceptions and challenges for patient management. Infect Drug Resist. 2015;8:119-28. doi: 10.2147/IDR.S66739. eCollection 2015.10.2147/IDR.S66739
- 16. Garin C, Bujadoux A. Paralysie par les tiques. (tick paralysis). J Med Lyon. 1922;71:765-767.
- 17. Mygland Å, Ljøstad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8-16,e1-4.
- 18. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.10.1128/CMR.18.3.484-509.2005
- 19. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003;3(8):489-500.10.1016/S1473-3099(03)00722-9
- 20. Mygland A, Ljøstad U, Fingerle V, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16,e1-4. doi: 10.1111/j.1468-1331.2009.02862.x.10.1111/j.1468-1331.2009.02862.x
- 21. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695. doi: 10.1016/S1474-4422(08)70119-4.10.1016/S1474-4422(08)70119-4
- 22. Eikeland R, Ljøstad U, Mygland A, Herlofson K, Løhaugen GC. European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol. 2012;19(3):480-487. doi: 10.1111/j.1468-1331.2011.03563.x.10.1111/j.1468-1331.2011.03563.x21999112
- 23. Ljøstad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol. 2010;17(1):118-123. doi: 10.1111/j.1468-1331.2009.02756.x.10.1111/j.1468-1331.2009.02756.x19645771